Good overview of developing drug therapies for renal cell carcinoma

The journal Oncology has published an interesting overview of current and developing systemic therapies for kidney cancer patients titled “Systemic Therapy in Renal Cell Carcinoma: Advancing paradigms.” I won’t bother to summarize here, as the article itself is a good, concise summary. Check it out.

More from RCC News & Research

• 

  FDA committee votes no to Tivozanib

• 

  Will you help us say thank you – and save lives?

• 

  Boo! Run for Life – Help raise some funds for kidney cancer research

• 

  Aveo, Astellas to launch new Tivo trial for renal cell carcinoma